[99mTc-MAG3-kidney function scintigraphy without and with captopril in the diagnosis of renovascular hypertension]. 1993

R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
Klinik mit Poliklinik für Nuklearmedizin, Johannes-Gutenberg-Universität, Mainz.

In this study, the diagnostic value of renal function scintigraphy performed both without and with ACE inhibition has been evaluated using the new radiopharmaceutical 99mTc-MAG3. In cases of decompensated renal artery stenoses, the typical scan finding with this tubular excreted agent was shown to be a distinct parenchymal nuclide retention in combination with a delayed appearance of the radiotracer in the pelvic system. Using this criterion in 43 patients with suspected renovascular hypertension, sensitivity and specificity were 89 and 88%, respectively. Bilateral positive findings were non-specific; excluding them from the study, specificity increased to 100%. In renal insufficiency, captopril scans seem to be of reduced diagnostic value. Summarising our experiences, renal function scintigraphy using 99mTc-MAG3 without and with captopril was proved to be a reliable non-invasive method to detect or exclude haemodynamically relevant renal artery stenosis.

UI MeSH Term Description Entries
D006978 Hypertension, Renovascular Hypertension due to RENAL ARTERY OBSTRUCTION or compression. Hypertension, Goldblatt,Goldblatt Syndrome,Goldblatt Hypertension,Renovascular Hypertension,Syndrome, Goldblatt
D011877 Radionuclide Imaging The production of an image obtained by cameras that detect the radioactive emissions of an injected radionuclide as it has distributed differentially throughout tissues in the body. The image obtained from a moving detector is called a scan, while the image obtained from a stationary camera device is called a scintiphotograph. Gamma Camera Imaging,Radioisotope Scanning,Scanning, Radioisotope,Scintigraphy,Scintiphotography,Imaging, Gamma Camera,Imaging, Radionuclide
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D017263 Technetium Tc 99m Mertiatide A technetium diagnostic aid used in renal function determination. 99mTc-MAG3,Tc 99m Mertiatide,Technetium-99m-MAG3,99mTc-Mercaptoacetyltriglycine,TechneScan MAG3,Technetium 99m Mercaptoacetylglycyl-glycyl-glycine,Technetium-99m-Mercaptoacetylglycylglycylglycine,Technetium-99m-Mercaptoacetyltriglycine,99m Mercaptoacetylglycyl-glycyl-glycine, Technetium,99m Mertiatide, Tc,99mTc MAG3,99mTc Mercaptoacetyltriglycine,MAG3, TechneScan,Mercaptoacetylglycyl-glycyl-glycine, Technetium 99m,Mertiatide, Tc 99m,Technetium 99m MAG3,Technetium 99m Mercaptoacetylglycyl glycyl glycine,Technetium 99m Mercaptoacetylglycylglycylglycine,Technetium 99m Mercaptoacetyltriglycine

Related Publications

R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
March 1994, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
May 1996, Annals of nuclear medicine,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
July 1994, Nuclear medicine communications,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
December 2001, Revista espanola de medicina nuclear,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
September 1988, Kidney international. Supplement,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
January 1992, Terapevticheskii arkhiv,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
July 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
September 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
August 1996, Investigative radiology,
R Piepenburg, and A Bockisch, and J Andreas, and C Düber, and P Kann, and G Maier, and K Hahn
December 1991, American journal of hypertension,
Copied contents to your clipboard!